## # ## |Contents||1| |---|---|---| |Foreword||2| |Reference and administrative|details|3| |Acknowledgements||4| |Structure, governance
and management||4| |Objectives and activities||7| |Achievements
and performance||7| |Financial
review||11| |Statement ofcorporate trustee|responsibilities|13| |Independent
examiner's
report||14| |Statement offinancial
activities||15| |Balance sheet
Statement ofcash flows||1617.| |Notes to the accounts||18| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |NHS Charities Together|NHS Charities Together|NHS Charities Together||2123,500| |---|---|---|---|---| |Individual|donations|received|from various donors|f20,217| |Investment|income|interest||2 5,183| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ||||||||I|| |---|---|---|---|---|---|---|---|---| |||||Unrestricted|Restricted|Endownrent|Total funds|Total funds| |||||2020/21|2020/21|2020/21|2020/21|2019/20| ||||Note|||||| |income and endowments||from:||||||| |Donations
and legacies||||18,117|125,600|0|143,717|4,252| |income from charitable|activities|||0|0|0|0|318| |Income from inmstments||||5,183|0|0|5183|8,551| |Sub total voluntary
income||||23,300|125,600|0|148,900|13,121| |Other income||||||||| |Transfer from NHS bodies||||||||| |Total income||||||||| |||||23,300|125,600|0|148,900|13,121| |Expenditure
on:||||||||| |Raising funds||||(22)|(3,000)|0|(3,022)|(290)| |Charitable
activities:||||||||| |Patient
benefit||||(21,466)|(610)|0|(22,078)|(90,234)| |Staff benefit||||(296)|(31,678)|0|(31,974)|(10,977)| |Other||||(100)|0|0|(100)|0| |Total||||(21,884)|(35,288)|0|(67,172)|(101,501)| |Net gains/(losses)
on|investments|||'l2,727||0|12,727|(182)| |Net income /(expenditure)||||'i4,143|90,312|0|104,455|(88,562)| |Transfer between
funds||||(30,000)|30,000|||| |Other recognised
gains/(losses):||||||||| |Net moment
in funds||||(15,857)|120,312|0|104,465|(88,562)| |Reconciiiadon
offunds||||||||| |Total income funds brought||forward||240,000|0|15,000|255,000|343,562| |Total income funds carried forward|||12|224,143|120,312|15,000|359,465|266,000| |||||Unrestricted|Restricted|Endowment|Total funds|Total funds| |---|---|---|---|---|---|---|---|---| |||||31 March|31 March|31March|31 March|31 March| |||||2021|2021|2021|2021|2020| ||||Note|||||| |Fixed Assets||||||||| |Tangible I Intangible|Assets|||||||| |Total fixed assets||||||||| |Curre nt assets||||||||| |Debtors|||9|743|0|0|743|74,208| |Cash held at Bank|||10|31,386|137,291|15,000|183,677|95,365| |Inwstment|||10|202,180|0|0|202,180|189,453| |Total current assets||||234,309|137,291|15,000|386,600|359,026| |Liabilities||||||||| |Creditors; amounts|falling|due within one year|11|(10,166)|(16,979)|0|(27,145)|(104,026)| |Net current assets||||224,143|120,312|15,000|369,465|255,000| |Total assets less current||liabilities||224,143|120,312|15,000|359,455|255,000| |Total net assets||||224,143|120,312|15,000|359,455|255,000| |The funds ofthe charity||||||||| |Unrestdcted
funds||||224,143|120,312||344,455|240,000| |Restricted
funds|||||0||0|0| |Endowment
funds||||||15,000|15,000|15,000| |Total charity funds|||12|224,143|120,312|15,000|359,455|255,000| ||||||||Unrestricted|Restricted|Endowment|Total funds|Total funds| |---|---|---|---|---|---|---|---|---|---|---|---| ||||||||2020/21|2020/21|2020/21|2020/2'f|2019/20| ||||||||6|8|||| |||||||Hots|||||| |Cash flows fram|operating|activities:|||||||||| |Net cash provided|by (used|in) operating||activities||13|(54,163)|137,291|0|83,128|(10,172)| |Interest received|||||||5,'I83||0|5,183|8,551| |Change
in cash and cash equivalents
period|||in|the|reporting||(48,980)|137,294|0|88,311|(1,621)| |Cash and cash equivalents
reporting
period||at the beginning|||ofthe||80,366|0|15,000|95,366|96,986| |Cash and cash equivalents
period||at the end|of|the|reporting|14|3'I,386|137,291|15,000|183,677|95,365| ## ## ## ## ## ## ## ## ## ## ## ## ## ||||Unrestricted|Restricted|Endowment|Total funds|Total funds| |---|---|---|---|---|---|---|---| ||||2020/21|2020/21|2020/21|2020/21|2019/20| ||||||||F| |Donations;|||||||| |Adult Secure Unit|||0|0||0|0| |Manchester||Services|229|0||229|0| |Research|&|Innovation|0|0||0|0| |Restricted|Funds||0|125,600||125,600|0| |General
Funds|||17,888|0||17,888|4,252| |Sub Total|||18,117|125,600||143,717|4,252| |Legacies:|||||||| |Sub Total|||0|||0|| |Total|||18,117|125,600||143,717|4,252| ## |||Unrestricted|Restricted|Endowment|Total funds|Total funds| |---|---|---|---|---|---|---| |||2020/21|2020/21|2020/21|2020/21|2019/20| |||||||F| |Fundraising|events|||||| |Adult Secure|Unit||||0|318| |Total||||||318| ## |||||Unrestricted|Restricted|Endowment|Total funds|Total hnds| |---|---|---|---|---|---|---|---|---| |||||2020/21|2020/21|2020/21|2020/21|2019/20| ||||||||6|| |Interest|from|Special Interest|Bearing Account||||49|102| |Interest from
investment||Royal London Asset Management||5,134|||5,134|8,449| |Total||||5,183|||5,183|8,551| ## ||||Unrestricted|Restricted|Endowment|Total funds|Total funds| |---|---|---|---|---|---|---|---| ||||2020/21|2020/21|2020/21|2020/21|2019/20| |Fundraising|non-pay|costs|22|3,000||3,022|290| |Total|||22|3,000||3,022|290| ## |||Unrestricted||Restri cted|Endowment|Total| |---|---|---|---|---|---|---| |||2020/21||2020/21|2020/21|2020/21| |Patient|benefit|(21,466)||(610)|0|(22,076)| |Staff benefit||(296)||(31,678)|0|(311974)| |Total||(21,762)||(32,288)|0|(54,050)| |2019/20||Activifies underlaken||directly||Total| |||Unrestricted|Restricted||Endowment|| |||2019/20||2019/20|2019/20 )|2019/20| |Patient|benefit|(90,234)|||0|(90,234)| |Staff benefit||(10,977)|||0|(10,977)| |Total||(101,211)|||0|(101,211)| ## ||Activities undertaken
directly
Unrestricted
Restricted|Activities undertaken
directly
Unrestricted
Restricted|Endowment|Total| |---|---|---|---|---| ||2020/21|2020/21|2020/21|2020/21| |Other Expenditure-Research|(100)|||(100)| |Total|(100)|0||(100)| |2019/20|Activities undertaken|directly||Total| ||Unrestricted
Restricted||Endowment|| ||2019/20|2019/20|2019/20|2019/20| ||E|||| |Other Expenditure-Research||0|0|0| |Total|||0|0| ## |||Unrestricted|Restricted|Endowment|Total funds|Total funds| |---|---|---|---|---|---|---| |||2020/21|2020/21|2020/21|2020/21|2019/20| |||||E||E| |Debtor|- GMMH NHS FTTransactions|743|||743|74,208| |Totai|debtors fatling due in less than|743||||74,208| ## ||||||Unrestricted|Restricted|Endowment|Total funds|Total funds| |---|---|---|---|---|---|---|---|---|---| ||||||2020121|2020121|2020/21|2020/21|2019/20| |||||||6||6|| |Cash|held|||'l4|31,386|137,291|15,000|183,677|95,365| |Royal|London Asset|Management|Inmstment||202,180|0|0|202,180|189,453| |Total|investments|and cash|||233,566|137,291|15,000|385,857|284,818| ## |||||||Unrestricted|Restricted|Endowment|Total funds|Total funds| |---|---|---|---|---|---|---|---|---|---|---| |||||||2020/21|2020/21|2020/21|2020/21|2019/20| |||||||||E||E| |Creditors||under|1|year||||||| |Creditors|-|GMMM||NHS|FTTransactions|(10,166)|(16,979)||(27,145)|(104,026)| |||||||(10,166)|(16,979)||(27,146)|(104,026)| ## ||||1 April 2020|||||31 March 2021| |---|---|---|---|---|---|---|---|---| |||Number of
individual
funds|Balance
brought
forward|Incoming
Resources|Investment
Gain!(Loss)|Resources
Expended|Transfer|Balance
carried
forward| ||||8|||||| |Unrestricted|funds|||||||| |Adult Secure Unit||1|12,'l20|0|0|0||12,120| |Manchester|Senlces|1|10,243|229|0|0||10,472| |Research 8|Innowt ton|3|48,601|0|0|(9,350)||39,251| |General Funds||3|169,036|23,071|12,727|(12,534)|(30,000)|162,300| |Resb icted funds||||||||| |Could 19|||0|125,600||(35,288)|3o,ooo|120,312| |Endowment|funds|||||||| |ESMI|||15,000|||||15,000| |Total funds||10|255,000|148,900|12,727|(57,172)|0|359;455| ## |||||Unresbicted|Restricted
'|Endowment|Total funds|Total funds| |---|---|---|---|---|---|---|---|---| |||||2020/21|2020/21|2020/21|2020/21|2019/20| ||||||K|||| |Net income
/ (expenditure)
for the reporting
per the statement
offinancial
activities)|||period (as|(15,857)|120,312|0|104,455|(88,562)| |Adjustments
for.||||||||| |(Gains) /|losses on investments|||(12,727)|0|0|(12,727)|182| |Dividends,|interest
and rents from in~tments|||(5,183)|0|0|(5,183)|(8,551)| |Purchase|ofinvestment|||0|0|0|0|90,000| |(Increase) / decrease||in debtors||73,464|0|0|73,464|(74,007)| |increase|/ (decrease)|in creditors||(93,860)|16,979|0|(76,881)|70,766| |Net cash|provided|by (used in) operating|activities|(54,163)|137,291|0|83,128|(10,172)| ## ||||Unrestricted|Restricted|Endowment|Total funds|Total funds| |---|---|---|---|---|---|---|---| ||||31 March 2021|31 March 2021|31 INarch 2021|31 March 2021|31 March 2020| ||||||||E| |Cash|at commerciai|bank and in hand|31,386|137,291|15,000|183,677|95,365| |Total|cash and cash equivalents||31,386|137,291|15,000|183,677|95,365| ##